<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bmjour</journal-id><journal-title-group><journal-title xml:lang="ru">Байкальский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Baikal Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-0715</issn><publisher><publisher-name>Irkutsk State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.57256/2949-0715-2025-4-2-12-21</article-id><article-id custom-type="elpub" pub-id-type="custom">bmjour-289</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Научные обзоры литературы</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Scientific literature reviews</subject></subj-group></article-categories><title-group><article-title>AP2A1 КАК НОВЫЙ РЕГУЛЯТОР КЛЕТОЧНОГО СТАРЕНИЯ: РОЛЬ В АДГЕЗИИ, ЦИТОСКЕЛЕТНОЙ ПЕРЕСТРОЙКЕ И ПЕРСПЕКТИВАХ ОМОЛОЖЕНИЯ КЛЕТОК</article-title><trans-title-group xml:lang="en"><trans-title>AP2A1 AS A NOVEL REGULATOR OF CELLULAR AGING: ROLE IN ADHESION, CYTOSKELETAL REMODELING, AND PROSPECTS FOR CELL REJUVENATION</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3285-5559</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воробьев</surname><given-names>Владимир Анатольевич</given-names></name><name name-style="western" xml:lang="en"><surname>Vorobev</surname><given-names>Vladimir A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор кафедры факультетской хирургии и урологии;</p><p> </p></bio><bio xml:lang="en"><p>Dr. Sci. (Med.), Professor of the Department of Faculty Surgery and Urology</p></bio><email xlink:type="simple">terdenecer@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щербатых</surname><given-names>Андрей Викторович</given-names></name><name name-style="western" xml:lang="en"><surname>Shcherbatykh</surname><given-names>Andrey V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, заведующий кафедрой факультетской хирургии и урологии; ректор</p></bio><bio xml:lang="en"><p>Dr. Sci. (Med.), Professor, Head of the Department of Faculty Surgery and Urology; rector</p></bio><email xlink:type="simple">irkutskii@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3135-4616</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малов</surname><given-names>Сергей Игоревич</given-names></name><name name-style="western" xml:lang="en"><surname>Malov</surname><given-names>Sergey I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, проректор по научной работе</p></bio><bio xml:lang="en"><p>Dr. Sci. (Med.), Professor, Vice-Rector for Scientific Work</p></bio><email xlink:type="simple">malovsergeii@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9278-9739</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лелявин</surname><given-names>Кирилл Борисович</given-names></name><name name-style="western" xml:lang="en"><surname>Lelyavin</surname><given-names>Kirill B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., доцент кафедры скорой медицинской помощи и медицины катастроф</p></bio><bio xml:lang="en"><p>Dr. Sci. (Med.), Associate Professor of the Department of Emergency Medical Care and Disaster Medicine</p></bio><email xlink:type="simple">lelyavinK@rambler.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1525-3425</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тухиев</surname><given-names>Артур Русланович</given-names></name><name name-style="western" xml:lang="en"><surname>Tukhiev</surname><given-names>Artur R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант кафедры факультетской хирургии и урологии</p></bio><bio xml:lang="en"><p>Graduate Student of the Department of Faculty Surgery and Urology</p></bio><email xlink:type="simple">atukhiev@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Иркутский государственный медицинский университет, Иркутск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Irkutsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Иркутский государственный медицинский университет, Ирктуск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Irkutsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Российская медицинская академия непрерывного профессионального образования, Иркутск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Irkutsk State Medical Academy of Postgraduate Education - branch of the Russian Medical Academy of Postgraduate Education</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>10</day><month>06</month><year>2025</year></pub-date><volume>4</volume><issue>2</issue><fpage>12</fpage><lpage>21</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Воробьев В.А., Щербатых А.В., Малов С.И., Лелявин К.Б., Тухиев А.Р., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Воробьев В.А., Щербатых А.В., Малов С.И., Лелявин К.Б., Тухиев А.Р.</copyright-holder><copyright-holder xml:lang="en">Vorobev V.A., Shcherbatykh A.V., Malov S.I., Lelyavin K.B., Tukhiev A.R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.bmjour.ru/jour/article/view/289">https://www.bmjour.ru/jour/article/view/289</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Старение клеток – один из ключевых факторов возраст-ассоциированных заболеваний, и понимание его механизмов открывает возможности для разработки антивозрастных стратегий. Недавние исследования показали, что белок AP2A1 (Adaptor Protein 2 Alpha 1 subunit), ранее известный как участник эндоцитоза, играет важную роль в поддержании сенесцентного фенотипа клеток. В стареющих клетках AP2A1 локализуется вдоль актиновых стресс-волокон, взаимодействует с интегрином β1 и способствует укреплению адгезии клеток к внеклеточному матриксу. Эти изменения позволяют сенесцентным клеткам поддерживать увеличенный размер и блокировать пролиферацию. Экспериментально показано, что подавление AP2A1 приводит к частичному омоложению клеток – уменьшению их размеров, снижению уровней маркеров сенесценции (p53, p21, SA-β-gal) и ослаблению адгезии [<xref ref-type="bibr" rid="cit1">1</xref>]. Напротив, повышение экспрессии AP2A1 в молодых клетках индуцирует ускоренное старение. Эти данные демонстрируют, что AP2A1 – не только маркер старения, но и активный регулятор клеточного состояния. Потенциально, AP2A1 может стать мишенью для антивозрастных мероприятий, направленных на модификацию адгезивных свойств сенесцентных клеток, ослабление их влияния на ткани и возможное обратимое омоложение.</p></sec><sec><title>Заключение</title><p>Заключение. В данной статье проводится систематический обзор литературы по роли AP2A1 в механизмах клеточного старения, его связи с интегриновыми путями и перспективам его модуляции в целях биомедицины.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Relevance</title><p>Relevance. Cellular aging is a major contributor to age-related diseases, and understanding its mechanisms opens avenues for anti-aging strategies.</p><p>The aim of this review is to systematically analyze the literature data on the role of the AP2A1 protein in the processes of cellular aging and rejuvenation.</p></sec><sec><title>Results</title><p>Results. Recent studies have identified AP2A1 (Adaptor Protein 2 Alpha 1 subunit), previously known for its role in endocytosis, as a crucial regulator of the senescent cell phenotype. In aged cells, AP2A1 localizes along actin stress fibers, interacts with integrin β1, and promotes strong adhesion to the extracellular matrix. These changes allow senescent cells to maintain their enlarged size and sustain cell cycle arrest. Experimental data show that AP2A1 knockdown leads to partial rejuvenation, characterized by reduced cell size, decreased senescence markers (p53, p21, SA-β-gal), and weakened adhesion. Conversely, AP2A1 overexpression in young cells accelerates senescence. These findings suggest that AP2A1 is not merely a biomarker of aging but an active regulator of cellular state. Targeting AP2A1 could offer a novel anti-aging therapeutic approach, aiming to modify senescent cell adhesion properties, mitigate their impact on tissues, and potentially induce partial rejuvenation.</p></sec><sec><title>Conclusion</title><p>Conclusion: This review provides a systematic analysis of AP2A1’s role in cellular aging, its link to integrin pathways, and the therapeutic potential of its modulation in biomedicine.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>клеточное старение</kwd><kwd>AP2A1</kwd><kwd>интегрин β1</kwd><kwd>сенесцентные клетки</kwd><kwd>стрессовые волокна</kwd><kwd>клеточная адгезия</kwd><kwd>омоложение клеток</kwd><kwd>антивозрастная терапия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cellular aging</kwd><kwd>AP2A1</kwd><kwd>integrin β1</kwd><kwd>senescent cells</kwd><kwd>stress fibers</kwd><kwd>cell adhesion</kwd><kwd>cell rejuvenation</kwd><kwd>anti-aging therapy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Calcinotto A., Alimonti A. Aging tumour cells to cure cancer: "pro-senescence" therapy for cancer. Swiss Med Wkly. 2017;147:w14367. https://doi.org/10.57187/smw.2017.14367</mixed-citation><mixed-citation xml:lang="en">Calcinotto A., Alimonti A. Aging tumour cells to cure cancer: "pro-senescence" therapy for cancer. Swiss Med Wkly. 2017;147:w14367. https://doi.org/10.57187/smw.2017.14367</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Shin E.Y., Park J.H., You S.T. et al. Integrin-mediated adhesions in regulation of cellular senescence. Sci Adv. 2020;6(19):eaay3909. https://doi.org/10.1126/sciadv.aay3909</mixed-citation><mixed-citation xml:lang="en">Shin E.Y., Park J.H., You S.T. et al. Integrin-mediated adhesions in regulation of cellular senescence. Sci Adv. 2020;6(19):eaay3909. https://doi.org/10.1126/sciadv.aay3909</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Childs B.G., Gluscevic M., Baker D.J. et al. Senescent cells: an emerging target for diseases of ageing. Nat Rev Drug Discov. 2017;16(10):718-735. https://doi.org/10.1038/nrd.2017.116</mixed-citation><mixed-citation xml:lang="en">Childs B.G., Gluscevic M., Baker D.J. et al. Senescent cells: an emerging target for diseases of ageing. Nat Rev Drug Discov. 2017;16(10):718-735. https://doi.org/10.1038/nrd.2017.116</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Dam D.H.M., Jelsma S.A., Yu J.M., Liu H., Kong B., Paller A.S. Flotillin and AP2A1/2 Promote IGF-1 Receptor Association with Clathrin and Internalization in Primary Human Keratinocytes. J Invest Dermatol. 2020;140(9):1743-1752.e4. https://doi.org/10.1016/j.jid.2020.01.015</mixed-citation><mixed-citation xml:lang="en">Dam D.H.M., Jelsma S.A., Yu J.M., Liu H., Kong B., Paller A.S. Flotillin and AP2A1/2 Promote IGF-1 Receptor Association with Clathrin and Internalization in Primary Human Keratinocytes. J Invest Dermatol. 2020;140(9):1743-1752.e4. https://doi.org/10.1016/j.jid.2020.01.015</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cho K.A., Ryu S.J., Oh Y.S. et al. Morphological adjustment of senescent cells by modulating caveolin-1 status. J Biol Chem. 2004;279(40):42270-42278. https://doi.org/10.1074/jbc.M402352200</mixed-citation><mixed-citation xml:lang="en">Cho K.A., Ryu S.J., Oh Y.S. et al. Morphological adjustment of senescent cells by modulating caveolin-1 status. J Biol Chem. 2004;279(40):42270-42278. https://doi.org/10.1074/jbc.M402352200</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wolfson M., Budovsky A., Tacutu R., Fraifeld V. The signaling hubs at the crossroad of longevity and age-related disease networks. Int J Biochem Cell Biol. 2009;41(3):516-520. https://doi.org/10.1016/j.biocel.2008.08.026</mixed-citation><mixed-citation xml:lang="en">Wolfson M., Budovsky A., Tacutu R., Fraifeld V. The signaling hubs at the crossroad of longevity and age-related disease networks. Int J Biochem Cell Biol. 2009;41(3):516-520. https://doi.org/10.1016/j.biocel.2008.08.026</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chantachotikul P, Liu S, Furukawa K, Deguchi S. AP2A1 modulates cell states between senescence and rejuvenation. Cell Signal. 2025;127:111616. https://doi.org/10.1016/j.cellsig.2025.111616</mixed-citation><mixed-citation xml:lang="en">Chantachotikul P, Liu S, Furukawa K, Deguchi S. AP2A1 modulates cell states between senescence and rejuvenation. Cell Signal. 2025;127:111616. https://doi.org/10.1016/j.cellsig.2025.111616</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">A newly discovered mechanism rejuvenates aging cells. ResOU. Website: https://resou.osaka-u.ac.jp/en/research/2025/20250207_1 [accessed: 19.02.2025].</mixed-citation><mixed-citation xml:lang="en">A newly discovered mechanism rejuvenates aging cells. ResOU. Website: https://resou.osaka-u.ac.jp/en/research/2025/20250207_1 [accessed: 19.02.2025].</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">PubChem. Ap2a1 - adaptor-related protein complex 2, alpha 1 subunit (house mouse) Available from: https://pubchem.ncbi.nlm.nih.gov/gene/Ap2a1/mouse [accessed: 19.02.2025].</mixed-citation><mixed-citation xml:lang="en">PubChem. Ap2a1 - adaptor-related protein complex 2, alpha 1 subunit (house mouse) Available from: https://pubchem.ncbi.nlm.nih.gov/gene/Ap2a1/mouse [accessed: 19.02.2025].</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">AP2A1 is upregulated upon replicative senescence of human fibroblasts to strengthen focal adhesions via integrin β1 translocation along stress fibers [Internet]. ResearchGate. Available from: https://www.researchgate.net/publication/373267731_AP2A1_is_upregulated_upon_replicative_senescence_of_human_fibroblasts_to_strengthen_focal_adhesions_via_integrin_b1_translocation_along_stress_fibers [accessed: 19.02.2025].</mixed-citation><mixed-citation xml:lang="en">AP2A1 is upregulated upon replicative senescence of human fibroblasts to strengthen focal adhesions via integrin β1 translocation along stress fibers [Internet]. ResearchGate. Available from: https://www.researchgate.net/publication/373267731_AP2A1_is_upregulated_upon_replicative_senescence_of_human_fibroblasts_to_strengthen_focal_adhesions_via_integrin_b1_translocation_along_stress_fibers [accessed: 19.02.2025].</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Geissler S., Textor M., Kühnisch J. et al. Functional comparison of chronological and in vitro aging: differential role of the cytoskeleton and mitochondria in mesenchymal stromal cells. PLoS One. 2012;7(12):e52700. https://doi.org/10.1371/journal.pone.0052700</mixed-citation><mixed-citation xml:lang="en">Geissler S., Textor M., Kühnisch J. et al. Functional comparison of chronological and in vitro aging: differential role of the cytoskeleton and mitochondria in mesenchymal stromal cells. PLoS One. 2012;7(12):e52700. https://doi.org/10.1371/journal.pone.0052700</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kenific CM, Wittmann T, Debnath J. Autophagy in adhesion and migration. J Cell Sci. 2016;129(20):3685-3693. https://doi.org/10.1242/jcs.188490</mixed-citation><mixed-citation xml:lang="en">Kenific CM, Wittmann T, Debnath J. Autophagy in adhesion and migration. J Cell Sci. 2016;129(20):3685-3693. https://doi.org/10.1242/jcs.188490</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Borghesan M, O'Loghlen A. Integrins in senescence and aging. Cell Cycle. 2017;16(10):909-910. https://doi.org/10.1080/15384101.2017.1316573</mixed-citation><mixed-citation xml:lang="en">Borghesan M, O'Loghlen A. Integrins in senescence and aging. Cell Cycle. 2017;16(10):909-910. https://doi.org/10.1080/15384101.2017.1316573</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Jun J.-I., Lau L. F. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010;12(7):676–685. https://doi.org/10.1038/ncb2070</mixed-citation><mixed-citation xml:lang="en">Jun J.-I., Lau L. F. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010;12(7):676–685. https://doi.org/10.1038/ncb2070</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wang C., Zhao D., Shah S.Z.A., Yang W., Li C., Yang L. Proteome Analysis of Potential Synaptic Vesicle Cycle Biomarkers in the Cerebrospinal Fluid of Patients with Sporadic Creutzfeldt-Jakob Disease. Mol Neurobiol. 2017;54(7):5177-5191. https://doi.org/10.1007/s12035-016-0029-6</mixed-citation><mixed-citation xml:lang="en">Wang C., Zhao D., Shah S.Z.A., Yang W., Li C., Yang L. Proteome Analysis of Potential Synaptic Vesicle Cycle Biomarkers in the Cerebrospinal Fluid of Patients with Sporadic Creutzfeldt-Jakob Disease. Mol Neurobiol. 2017;54(7):5177-5191. https://doi.org/10.1007/s12035-016-0029-6</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Rapisarda V., Borghesan M., Miguela V. et al. Integrin Beta 3 Regulates Cellular Senescence by Activating the TGF-β Pathway. Cell Rep. 2017;18(10):2480-2493. https://doi.org/10.1016/j.celrep.2017.02.012</mixed-citation><mixed-citation xml:lang="en">Rapisarda V., Borghesan M., Miguela V. et al. Integrin Beta 3 Regulates Cellular Senescence by Activating the TGF-β Pathway. Cell Rep. 2017;18(10):2480-2493. https://doi.org/10.1016/j.celrep.2017.02.012</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Mulder G.D., Vande Berg J.S. Cellular senescence and matrix metalloproteinase activity in chronic wounds. Relevance to debridement and new technologies. J Am Podiatr Med Assoc. 2002;92(1):34–37. https://doi.org/10.7547/87507315-92-1-34</mixed-citation><mixed-citation xml:lang="en">Mulder G.D., Vande Berg J.S. Cellular senescence and matrix metalloproteinase activity in chronic wounds. Relevance to debridement and new technologies. J Am Podiatr Med Assoc. 2002;92(1):34–37. https://doi.org/10.7547/87507315-92-1-34</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Telgenhoff D., Shroot B. Cellular senescence mechanisms in chronic wound healing. Cell Death Differ. 2005;12(7):695–698. https://doi.org/10.1038/sj.cdd.4401632</mixed-citation><mixed-citation xml:lang="en">Telgenhoff D., Shroot B. Cellular senescence mechanisms in chronic wound healing. Cell Death Differ. 2005;12(7):695–698. https://doi.org/10.1038/sj.cdd.4401632</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kassianidou E., Kumar S. A biomechanical perspective on stress fiber structure and function. Biochim Biophys Acta Mol Cell Res. 2015;1853(11 Pt B):3065–3074. https://doi.org/10.1016/j.bbamcr.2015.04.006</mixed-citation><mixed-citation xml:lang="en">Kassianidou E., Kumar S. A biomechanical perspective on stress fiber structure and function. Biochim Biophys Acta Mol Cell Res. 2015;1853(11 Pt B):3065–3074. https://doi.org/10.1016/j.bbamcr.2015.04.006</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Vacurova E., Vlachova E., Stursa J. et al. Targeting Mitochondrial Integrity as a New Senolytic Strategy. Aging Dis. https://doi.org/10.14336/AD.2024.1100</mixed-citation><mixed-citation xml:lang="en">Vacurova E., Vlachova E., Stursa J. et al. Targeting Mitochondrial Integrity as a New Senolytic Strategy. Aging Dis. https://doi.org/10.14336/AD.2024.1100</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
